These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8690621

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH, Masoodi SR, Laway BA, Wani AI, Bashir MI.
    J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [Abstract] [Full Text] [Related]

  • 9. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB, Fonseca VA, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165
    [Abstract] [Full Text] [Related]

  • 11. Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes.
    Peters Harmel AL, Kendall DM, Buse JB, Boyle PJ, Marchetti A, Lau H.
    Curr Med Res Opin; 2004 Jul 28; 20(2):215-23. PubMed ID: 15006017
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The beta cell function in NIDDM patients with secondary failure: a three year follow-up of combined oral hypoglycemic and insulin therapy.
    Greco AV, Caputo S, Bertoli A, Ghirlanda G.
    Horm Metab Res; 1992 Jun 28; 24(6):280-3. PubMed ID: 1634193
    [Abstract] [Full Text] [Related]

  • 17. [Renewal of oral therapy for diabetes mellitus after secondary failure].
    Guberman D.
    Harefuah; 1989 Nov 01; 117(9):240-1. PubMed ID: 2693275
    [Abstract] [Full Text] [Related]

  • 18. [Changes in metabolic control after interruption of oral hypoglycemic agents in type II diabetic patients with secondary failure during combined therapy].
    De Mattia G, Laurenti O, Tullo MG, Ventura C, Albi F.
    Clin Ter; 1988 Oct 31; 127(2):119-22. PubMed ID: 2976347
    [No Abstract] [Full Text] [Related]

  • 19. Treating non-insulin-dependent diabetes. Oral agents or insulin?
    Shlossberg AH.
    Can Fam Physician; 1993 Jan 31; 39():119-20, 123-6. PubMed ID: 8435549
    [Abstract] [Full Text] [Related]

  • 20. Combinations of insulin and oral hypoglycemic agents in diabetes mellitus type 2.
    Pagkalos EM.
    Diabetes Res Clin Pract; 2011 Aug 31; 93 Suppl 1():S100-1. PubMed ID: 21864738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.